|
|
Results |
The fatty acid profile EFA-SRä will measure the amount of about 30 key fatty acids in your blood, selected from more than 200 chemicals and fats found in blood or tissues. Selecting the proper fatty acids and knowing how to interpret fluctuations is one of the most difficult issues in diagnosis.
In cases like this, more is not better. Reporting more substances would not help but rather would confuse your results. There are millions of substances in the body. The trick is to select the important ones.
It is like news about stocks: there are millions of news items, but you only want to know the relevant ones or else you will waste your life reading and miss the opportunities to make money.
The fatty acid profile EFA-SRä provides those key fatty acids that are needed to make decisions about treatment which have been described by Dr. Siguel. Other fatty acids can be measured for research purposes.
A series of complex evaluations will allow us to determine whether some levels of fatty acids are too high or too low, and whether your body stores of these fats are also likely too high or too low. We will compare several key ratios and determine whether or not you have a fatty acid metabolic block, and exactly which fatty acids you need to eat or avoid.
The Fatty
Acid Profile EFA-SRä has several distinguishing features.
The fatty acid profile EFA-SRÔ
provides percentages, ratios, and concentrations for fatty acids.
The use of percentages and concentrations as reported in the fatty acid profile
EFA-SRä
has been deemed unique and useful and awarded US Patent No. 5075101,
"Method And Apparatus for Diagnosis of Fatty Acid or Lipid
Abnormalities." These numbers are critical to the proper diagnosis of
abnormalities caused by a Relative vs. an Absolute deficiency of EFAs.
Relative deficiencies are in part caused by excessive amounts of saturated and
monounsaturated fatty acids (SFAs and MUFAs). Such deficiencies
can often be corrected with appropriate weight loss and PUFA
supplements. Absolute deficiencies require taking large quantities of EFAs, to
bring adipose tissue stores up to healthy levels. Sometimes intravenous lipids
are needed.
For guidelines about the diagnosis of these
abnormalities in patients with elevated plasma lipids, see Siguel and Lerman,
"Fatty Acid Patterns in Patients with Angiographically Documented Coronary
Artery Disease. Metabolism 1994; 43:982-993." For the diagnosis of
these abnormalities in patients with low plasma lipids caused by fat
malabsorption, such as Inflammatory Bowel Disease and Cystic Fibrosis, see Siguel
and Lerman, "Fatty Acid Patterns in Patients with chronic intestinal
disease". Metabolism 1996.
For many years, textbooks of medicine have
acknowledged the trienoic/tetraenoic (also known as 20:3w9/20:4w6,
Mead/Arachidonic acid, or "T/T") ratio as a test for EFA
deficiency. Using older and less sensitive technologies, researchers
established that T/T values above 0.2 or 0.4 are indicators of EFA deficiency
(as still reported in many medical publications). Using modern technology,
Siguel reported that levels of T/T above 0.02 are indicative of insufficient
EFA levels. In recent years, other markers of EFA status have been developed.
The fatty acid profile EFA-SRä
uses highly sophisticated technology to achieve narrow ranges for
healthy reference levels, and therefore is able to detect the biochemical
changes that characterize the early onset of EFA deficiency. It is
desirable to diagnose and treat an EFA abnormality before it becomes severe and
causes cell damage.
Fatty acids are analyzed using High
Resolution Capillary Column Gas Liquid Chromatography (GLC). The method
quantifies plasma levels of fatty acids from chain length C14 up to C24,
including the EFAs, arachidonic acid, eicosapentaenoic acid (EPA),
docosahexaenoic acid (DHA), the eicosanoid precursors and key trans
fatty acids. Similar methods can be used with red cells or adipose tissue.
Several profiles are available to include major saturated and monounsaturated
(w7 and w9) fatty acids, the EFAs (linoleic and linolenic), EFA derivatives,
total w6 and w3, including 20:5w3 (EPA), 22:5w3 and 22:6w3 (DHA).
In addition, different types of trans fatty acids associated with
hydrogenated oils or other processed fats can be measured. Usually a physician
orders a profile with about 25-30 major cis fatty acids, or one with the
cis and several trans fatty acids.
The methods used to prepare the fatty acid
profile EFA-SRä
have been called "state of the art" by the review committees
of the National Institute of Health that examined them. A laboratory technician
spends many hours analyzing each sample to obtain adequate peak identification.
It takes more than 5 hours to prepare chemical extracts from the blood of each
sample, and more than 3 hours to have each sample analyzed by GLC
(compared with minutes needed for the analysis of other substances). Additional
time is required to review the chromatogram and insure that each peak is
properly integrated (i.e., that the amount of each substance is properly
calculated). Considerable time is spent on quality control.
The Fatty Acid Profile EFA-SRä compares the
patient’s results to results from other patients and from healthy subjects and
compares the relative % of each fatty acid (its proportion of total fatty
acids) and its concentration. This allows us to identify relative vs.
absolute deficiencies, a classification of fatty acid abnormalities
described in Dr. Siguel’s patent and in several peer-reviewed publications.
This classification is critical to optimal diagnosis and treatment. The report
includes charts and tables, designed using software developed by Dr. Siguel,
that illustrate whether a patient is considered to have a relative or absolute
deficiency. These graphs, needed to diagnose these abnormalities, constitute
some of the aspects of US Patent No. 5075101.
In addition to an absolute or relative
deficiency of EFAs, most patients have an imbalance of w3 vs. w6 fatty acids,
and an imbalance of EFA derivatives. Our experience analyzing hundreds of
patients and research subjects has revealed that imbalances of w3 vs. w6 fatty
acids or fatty acid excesses require special analytical methods.
Relative excesses or deficiencies of one
fatty acid alter the metabolism of the others. The fatty acid profile EFA-SRä can help
to diagnose metabolic blocks and provides guidelines for further diagnostic
testing of defects in the metabolic conversion of EFA precursors to
derivatives. A metabolic block in the formation of EFA derivatives requires
treatment with specific supplements to bypass the block. This aspect of the
test is in part described in US Patent No. 5075101 and is critical for the
treatment of several disorders.
Metabolic blocks have been found in patients with various conditions, including
diabetes mellitus, alcoholism, and abnormal lipids. The movie "Lorenzo’s
oil" explained the use of special fatty acids to prevent the formation of
long chain SFAs which lead to neurological damage in some patients. In those
patients, excessive levels of very long chain saturated fatty acids and low
levels of EFAs are characteristic of the disease.
See a physician’s guide to the diagnosis of EFA
abnormalities by Siguel: "Essential and Trans Fatty Acid Metabolism
in Health and Disease." Nutrition Issue. Contemporary Therapy,
1994; 20(9): 500-510.
The fatty acid profile EFA-SRä relies on
an extensive database of test results on research subjects as well as patients
with unusual metabolic problems. To our knowledge, nobody else has access to a
similar database.
The fatty acid profile EFA-SRä is based
on reference values developed from samples from subjects without known disease,
as well as samples from a population group with "normal" lipid
levels. These reference levels provide 5, 10, 25, 50, 75, 90 and 95 percentiles
for cis and trans fatty acids, values which help physicians compare a
patient with other subjects.
Our research has identified the fatty acid
profiles associated with abnormal TC/HDLC, high TG, low HDL, diabetes mellitus,
and various other health conditions. Depending on the results of your profile,
we can provide specific guidelines on a mixture of fatty acids likely to bring
your TC/HDLC ratio towards a value associated with reduced risk of heart
disease.
Individualized reports are prepared for each
patient, leading to specific treatment recommendations by the
health provider.
We will be able to present you with a diet suited to your individual needs. This diet will bring your fatty acid profile closer to ideal levels. As a "side effect," you may lose weight, have more energy, feel more "alert," reduce your chances for cancer and heart disease, and improve allergies and asthma! Most important, you will have the satisfaction of knowing you are doing what is the best for your body and giving your body the nutrients it really needs to reach its ideal-- you are literally taking your life into your own hands.
Doctors and patients who seek to correct an imbalance or deficiency of EFs by using oil supplements and foods rich in EFAs may experience differing results. They may find that their TC or TG increase, that their TC/HDLC ratio rises, or that a low HDL does not increase.
To find the reasons for individual failure, it would be necessary to spend millions of dollars to analyze thousands of substances in the body, because each person has a very different body chemistry. Obviously, this approach is not practical. Instead, we seek to identify the most likely reasons for failure, which can be one of many factors discussed here.
In my experience, the most likely reason for lack of improvement is that body fat composition has not been changed significantly enough to create a healthy fatty acid profile. Most people have many pounds of fat in their body. At the rate of a few tablespoons of oil per day, it can take years to substantially change the mixture of fats in all parts of the body.
It is possible to correct iron or other vitamin deficiencies in a few weeks by taking a few pills. However, unlike a single vitamin capsule that can contain the mineral dosage required by the body for an entire month, fatty acid supplements cannot fix the problem quickly. One cannot consume a gallon of oil a day.
|
All information on this website is copyrighted; see use and permission to reproduce. The information in this website is not medical advice, merely a general scientific discussion. See warnings & disclaimers. |
|
|
© 1998 Edward N. Siguel. All rights reserved |
modified 9/16/98 |